Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Using simulated scenarios to train front-line staff in the COVID-19 response

Tucked away in an unassuming annexe at the back of the John Radcliffe Hospital you will find a powerhouse at the centre of training NHS staff on the COVID-19 front line. This is OxSTaR (Oxford Simulation, Teaching and Research), the University of Oxford’s state-of-the-art medical simulation, teaching and research facility. This unit, led by Dr Helen Higham, is part of the Nuffield Division of Anaesthetics in the Nuffield Department of Clinical Neurosciences. It embodies the incredible impact that can be achieved when robust research meets clinical practice — and never more so than in a global crisis such as the one in which we now find ourselves.

For 12 years, OxSTaR has been running simulated scenarios — complete with highly realistic functioning models of patients known as manikins — to understand and improve how healthcare professionals work together and interact with their environment and equipment. They have used the insights gained to provide training across Oxford University Hospitals (OUH). Recent weeks have seen them rise to the unique challenge of supporting front-line clinical staff during a pandemic. Helen is full of praise for everyone involved in this effort, particularly the members of her core team: Rosie Warren, Alan Inglis, Russ Sinclair, Charlie McDermott, Wendy Washbourn and Paul Hambidge. This outstanding example of the University and OUH working in partnership has also hinged on the enthusiastic engagement of OxSTaR’s faculty (largely anaesthetics and intensive care consultants and trainees), and support from OUH Infection Prevention and Control team, Corporate Education, the Chief Medical and Nursing Officers and Oxford Medical Imaging.

Read more on the University of Oxford Medium channel

Similar stories

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.